Pharming Group (OTCMKTS:PHGUF – Get Free Report)’s share price fell 8.5% on Wednesday . The stock traded as low as $0.75 and last traded at $0.75. 850 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 3,802 shares. The stock had previously closed at $0.82.
Pharming Group Price Performance
The company has a quick ratio of 1.16, a current ratio of 1.43 and a debt-to-equity ratio of 0.14. The company has a market cap of $492.57 million, a price-to-earnings ratio of -75.50 and a beta of 1.18. The company has a fifty day simple moving average of $0.82 and a two-hundred day simple moving average of $0.97.
Pharming Group Company Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
See Also
- Five stocks we like better than Pharming Group
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- What is Put Option Volume?
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- What is the Hang Seng index?
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
